
CAS: 1401090-53-6

Carbamic acid, N-[1-[2-(4-fluorophenyl)-4-thiazolyl]-1-methylethyl]-, (3S)-1-azabicyclo[2.2.2]oct-3-yl ester
CAS:1401090-53-6
Formula:
C20H24FN3O2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
389.4869
Ref: IN-DA001C15
2mg | 81.00 € | ||
5mg | 129.00 € | ||
10mg | 156.00 € | ||
25mg | 314.00 € | ||
50mg | 524.00 € | ||
100mg | 555.00 € | ||
250mg | To inquire |
Estimated delivery in United States, on Thursday 27 Mar 2025

Ibiglustat
CAS:1401090-53-6
Ibiglustat (GZ402671) inhibits Glucosylceramide synthase, may treat Fabry disease by preventing GL-3 synthesis.
Formula:
C20H24FN3O2S
Purity:
97.97% - 99.14%
Color and Shape:
Solid
Molecular weight:
389.49
Ref: TM-T4473
1mg | 39.00 € | ||
5mg | 97.00 € | ||
10mg | 168.00 € | ||
25mg | 298.00 € | ||
50mg | 430.00 € | ||
100mg | 605.00 € | ||
200mg | 815.00 € | ||
1mL*10mM (DMSO) | 90.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025

(S)-QUINUCLIDIN-3-YL (2-(2-(4-FLUOROPHENYL)THIAZOL-4-YL)PROPAN-2-YL)CARBAMATE
CAS:1401090-53-6
Purity:
95.0%
Color and Shape:
Liquid, No data available.
Molecular weight:
389.489990234375
Ref: 10-F504966
250mg | To inquire |
Estimated delivery in United States, on Tuesday 8 Apr 2025

Ibiglustat
CAS:1401090-53-6
Ibiglustat is a heterobicyclic compound that inhibits the enzyme glucosylceramide synthase, which is involved in …
Formula:
C20H24FN3O2S
Purity:
Min. 95%
Molecular weight:
389.49 g/mol
Ref: 3D-BGC09053
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |